EUVIMEDEUVIMED entdecken
Übersichtsarbeit

A Review of Emerging Evidence and Clinical Applications of Hyperbaric Oxygen Therapy

Sakshi Hiren Patel iD, Juliet Joy Joseph, Tejal R Gandhi, Anita Mehta, Akshay Shah

Journal of Intensive Care Medicine · 2025-03 · 40 (3) · 341-351

DOI: 10.1177/08850666241313136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Intensive Care Medicine, online erschienen am 15.01.2025. Verfasst von Sakshi Hiren Patel und 4 weiteren Autor:innen. Beteiligte Einrichtung: Anand Pharmacy College, Anand, Gujarat, India. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, COVID-19. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves administering 100% oxygen at increased atmospheric pressure to enhance oxygen delivery to tissues. Initially developed for decompression sickness, HBOT has since been utilized for a wide range of medical conditions, including severe infections, non-healing wounds, and, more recently, COVID-19.

Objective

This review explores the historical development of HBOT, its principles, its emerging role in the management of and its outcome as treatment in COVID-19, particularly in mitigating inflammation, hypoxemia, and oxidative stress.

Methods

A comprehensive review of the literature was conducted, analyzing case reports and case series that examined the effectiveness of HBOT in various clinical scenarios, with a focus on COVID-19.

Results

HBOT has been shown to enhance tissue oxygenation, reduce inflammation, and modulate oxidative stress, thereby improving clinical outcomes in patients with severe COVID-19. The therapy's ability to increase dissolved oxygen levels in blood and tissues, independent of hemoglobin, makes it particularly beneficial in conditions like COVID-19, where hypoxemia and inflammation are prominent.

Conclusion

HBOT offers a promising adjunctive treatment for severe COVID-19, with the potential to reduce mortality and improve recovery by targeting key pathophysiological processes such as hypoxemia, inflammation, and oxidative stress. Further research is warranted to optimize treatment protocols and confirm long-term benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperbaric OxygenationCOVID-19HumansOxidative StressHypoxiaSARS-CoV-2Inflammation

Stichwörter der Autor:innen

COVID-19SARS-CoV-2hyperbaric oxygen therapyhyperbaric oxygenationhypoxemiaoxidative stress

Autor:innen und Institutionen

  • Anand Pharmacy College, Anand, Gujarat, India.

ORCID-Profile: Sakshi Hiren Patel

Zitieren

APA

Patel, S. H., Joseph, J. J., Gandhi, T. R., Mehta, A., & Shah, A. (2025). A Review of Emerging Evidence and Clinical Applications of Hyperbaric Oxygen Therapy. Journal of Intensive Care Medicine, 40(3), 341-351. https://doi.org/10.1177/08850666241313136

Vancouver

Patel SH, Joseph JJ, Gandhi TR, Mehta A, Shah A. A Review of Emerging Evidence and Clinical Applications of Hyperbaric Oxygen Therapy. Journal of Intensive Care Medicine. 2025;40(3):341-351. doi:10.1177/08850666241313136

BibTeX
@article{Patel2025,
  author = {Patel, Sakshi Hiren and Joseph, Juliet Joy and Gandhi, Tejal R and Mehta, Anita and Shah, Akshay},
  title = {A Review of Emerging Evidence and Clinical Applications of Hyperbaric Oxygen Therapy},
  journal = {Journal of Intensive Care Medicine},
  year = {2025},
  volume = {40},
  number = {3},
  pages = {341--351},
  doi = {10.1177/08850666241313136}
}
Kostenlos starten →